<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Contraception Assessment Algorithm</title>
    <style>
        /* --- Google Font --- */
        @import url('https://fonts.googleapis.com/css2?family=Roboto:wght@300;400;500;700&display=swap');

        /* --- CSS Reset & Base Styles --- */
        :root {
            --primary-color: #005A9C; /* Professional Blue */
            --secondary-color: #00796B; /* Calming Teal */
            --background-color: #f4f7f9;
            --card-background: #ffffff;
            --text-color: #333;
            --light-text-color: #666;
            --border-color: #e0e0e0;
            --shadow: 0 4px 8px rgba(0,0,0,0.05);
            --ok-color: #E8F5E9; /* Light Green */
            --caution-color: #FFF3E0; /* Light Orange */
            --danger-color: #FFEBEE; /* Light Red */
        }

        * {
            box-sizing: border-box;
            margin: 0;
            padding: 0;
        }

        body {
            font-family: 'Roboto', sans-serif;
            background-color: var(--background-color);
            color: var(--text-color);
            line-height: 1.6;
            font-size: 16px;
        }

        /* --- Layout & Containers --- */
        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 20px;
        }

        header {
            text-align: center;
            margin-bottom: 40px;
            padding: 20px;
            background-color: var(--card-background);
            border-radius: 12px;
            box-shadow: var(--shadow);
        }

        header h1 {
            color: var(--primary-color);
            font-weight: 700;
            font-size: 2.5rem;
            margin-bottom: 5px;
        }
        
        header p {
            color: var(--light-text-color);
            font-size: 1.1rem;
        }

        .step-card {
            background-color: var(--card-background);
            margin-bottom: 30px;
            padding: 30px;
            border-radius: 12px;
            box-shadow: var(--shadow);
            border-left: 5px solid var(--primary-color);
        }

        /* --- Typography & Content --- */
        h2 {
            font-size: 1.8rem;
            font-weight: 500;
            color: var(--primary-color);
            margin-bottom: 20px;
            display: flex;
            align-items: center;
        }
        
        h2 .step-number {
            background-color: var(--primary-color);
            color: white;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            display: inline-flex;
            align-items: center;
            justify-content: center;
            font-size: 1.5rem;
            margin-right: 15px;
            font-weight: 700;
        }

        h3 {
            font-size: 1.3rem;
            color: var(--secondary-color);
            margin-top: 25px;
            margin-bottom: 10px;
            font-weight: 500;
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 5px;
        }

        ul, dl {
            padding-left: 20px;
        }

        li, dd {
            margin-bottom: 10px;
        }

        strong {
            font-weight: 500;
            color: var(--text-color);
        }

        /* --- Special Highlight Box --- */
        .highlight-box {
            background-color: #eef7ff;
            border: 1px solid #b3d7f5;
            border-left: 5px solid var(--primary-color);
            padding: 20px;
            margin-top: 20px;
            border-radius: 8px;
        }
        
        .highlight-box ul {
            list-style-type: none;
            padding-left: 0;
        }
        
        .highlight-box li {
            position: relative;
            padding-left: 30px;
        }

        .highlight-box li::before {
            content: '✓';
            color: var(--secondary-color);
            font-weight: bold;
            position: absolute;
            left: 0;
            top: 0;
            font-size: 1.2rem;
        }


        /* --- Table Styling --- */
        .table-wrapper {
            overflow-x: auto;
            margin-top: 20px;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            text-align: center;
        }

        th, td {
            padding: 12px 15px;
            border: 1px solid var(--border-color);
        }

        thead th {
            background-color: var(--secondary-color);
            color: white;
            font-weight: 500;
        }
        
        tbody tr:nth-child(even) {
            background-color: #fafafa;
        }
        
        td:first-child {
            text-align: left;
            font-weight: 500;
        }

        .ukmec-ok { background-color: var(--ok-color); }
        .ukmec-caution { background-color: var(--caution-color); font-weight: bold; }
        .ukmec-danger { background-color: var(--danger-color); font-weight: bold; }

        .ukmec-caution span, .ukmec-danger span {
            color: #C62828;
        }

        /* --- Footer --- */
        footer {
            text-align: center;
            padding: 20px;
            margin-top: 20px;
            color: var(--light-text-color);
            font-style: italic;
        }
        
        /* --- Responsive Design --- */
        @media (max-width: 768px) {
            header h1 {
                font-size: 2rem;
            }
            .step-card {
                padding: 20px;
            }
            h2 {
                font-size: 1.5rem;
            }
        }
    </style>
</head>
<body>

    <div class="container">
        <header>
            <h1>Contraception Assessment Algorithm</h1>
            <p>A Quick Reference Aide-Memoire for Clinicians</p>
        </header>

        <main>
            <!-- Step 1 -->
            <section class="step-card">
                <h2><span class="step-number">1</span>Initial Patient Assessment & Discussion</h2>
                <h3>Establish Patient Needs</h3>
                <ul>
                    <li>Discuss preferences, reproductive goals, lifestyle, and partner's views.</li>
                    <li>Provide information on <strong>all</strong> available methods, highlighting the high efficacy of Long-Acting Reversible Contraception (LARC): Implants, IUDs, Injectables.</li>
                    <li>Compare methods based on efficacy (perfect vs. typical use), side effects, risks/benefits, and return to fertility.</li>
                </ul>
                <h3>Screening & Safeguarding</h3>
                <ul>
                    <li><strong>STI Risk:</strong> Assess and offer screening if appropriate. Promote condom use for dual protection.</li>
                    <li><strong>Vulnerability:</strong> Assess for sexual abuse or coercion.</li>
                    <li><strong>Under 16:</strong> Assess using <strong>Fraser Criteria</strong> (competence to consent). Document clearly.</li>
                </ul>
            </section>

            <!-- Step 2 -->
            <section class="step-card">
                <h2><span class="step-number">2</span>Exclude Pregnancy</h2>
                <p>You can be "<strong>Reasonably Certain</strong>" a patient is NOT pregnant if they have no signs/symptoms of pregnancy AND one of the following is true:</p>
                <div class="highlight-box">
                    <ul>
                        <li>It is within the first <strong>5 days</strong> of a normal menstrual period.</li>
                        <li>They are &lt;21 days postpartum (and not breastfeeding).</li>
                        <li>They are &lt;6 months postpartum, fully breastfeeding, and amenorrhoeic.</li>
                        <li>It is within the first <strong>5 days</strong> after an abortion or miscarriage.</li>
                        <li>They have been correctly and consistently using a reliable contraceptive method.</li>
                        <li>They have not had intercourse for &gt;21 days and have a negative high-sensitivity pregnancy test.</li>
                    </ul>
                </div>
                <p style="margin-top: 15px;"><strong>If pregnancy cannot be excluded:</strong> Offer Emergency Contraception (EC). Consider "Quick Starting" a suitable method (e.g., implant, POP, CHC) after discussing risks and advising a follow-up pregnancy test.</p>
            </section>

            <!-- Step 3 -->
            <section class="step-card">
                <h2><span class="step-number">3</span>Medical Eligibility Quick-Check (UKMEC)</h2>
                <p>Use this table to identify major contraindications. <strong>UKMEC 4 = Unacceptable Risk (Do Not Use)</strong>; <strong>UKMEC 3 = Risks > Benefits (Avoid)</strong>.</p>
                <div class="table-wrapper">
                    <table>
                        <thead>
                            <tr>
                                <th>Condition / Risk Factor</th>
                                <th>Combined Hormonal (CHC)</th>
                                <th>POP & Implant</th>
                                <th>Injectable</th>
                                <th>IUC (Cu/LNG)</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td><strong>Migraine with Aura</strong> (current or past)</td>
                                <td class="ukmec-danger"><span>4</span> (past: <span>3</span>)</td>
                                <td class="ukmec-ok">✅</td>
                                <td class="ukmec-ok">✅</td>
                                <td class="ukmec-ok">✅</td>
                            </tr>
                            <tr>
                                <td><strong>History of VTE, Stroke, IHD</strong></td>
                                <td class="ukmec-danger"><span>4</span></td>
                                <td class="ukmec-ok">✅</td>
                                <td class="ukmec-ok">✅</td>
                                <td class="ukmec-ok">✅</td>
                            </tr>
                            <tr>
                                <td><strong>Current VTE</strong> (on anticoagulants)</td>
                                <td class="ukmec-danger"><span>4</span></td>
                                <td class="ukmec-ok">✅</td>
                                <td class="ukmec-ok">✅</td>
                                <td class="ukmec-ok">✅</td>
                            </tr>
                            <tr>
                                <td><strong>Hypertension</strong> (BP ≥160/100 mmHg)</td>
                                <td class="ukmec-danger"><span>4</span></td>
                                <td class="ukmec-ok">✅</td>
                                <td class="ukmec-caution">3</td>
                                <td class="ukmec-ok">✅</td>
                            </tr>
                            <tr>
                                <td><strong>Multiple CV Risk Factors</strong></td>
                                <td class="ukmec-caution">3</td>
                                <td class="ukmec-ok">✅</td>
                                <td class="ukmec-caution">3</td>
                                <td class="ukmec-ok">✅</td>
                            </tr>
                             <tr>
                                <td><strong>Smoker, age ≥35</strong></td>
                                <td class="ukmec-caution">3 or <span>4</span></td>
                                <td class="ukmec-ok">✅</td>
                                <td class="ukmec-ok">✅</td>
                                <td class="ukmec-ok">✅</td>
                            </tr>
                            <tr>
                                <td><strong>BMI ≥35 kg/m²</strong></td>
                                <td class="ukmec-caution">3</td>
                                <td class="ukmec-ok">✅</td>
                                <td class="ukmec-ok">✅</td>
                                <td class="ukmec-ok">✅</td>
                            </tr>
                            <tr>
                                <td><strong>Postpartum <6 wks</strong> (breastfeeding)</td>
                                <td class="ukmec-danger"><span>4</span></td>
                                <td class="ukmec-ok">✅</td>
                                <td class="ukmec-ok">✅</td>
                                <td class="ukmec-ok">✅</td>
                            </tr>
                            <tr>
                                <td><strong>Current or Past Breast Cancer</strong></td>
                                <td class="ukmec-danger"><span>4</span></td>
                                <td class="ukmec-danger">3-<span>4</span></td>
                                <td class="ukmec-danger">3-<span>4</span></td>
                                <td class="ukmec-ok">✅ (Cu-IUD)</td>
                            </tr>
                             <tr>
                                <td><strong>Distorted Uterine Cavity / Active PID</strong></td>
                                <td>N/A</td>
                                <td>N/A</td>
                                <td>N/A</td>
                                <td class="ukmec-danger">3-<span>4</span> (Do Not Insert)</td>
                            </tr>
                        </tbody>
                    </table>
                </div>
            </section>
            
            <!-- Step 4 -->
            <section class="step-card">
                <h2><span class="step-number">4</span>Assess for Key Drug Interactions</h2>
                 <dl>
                    <dt><h3>Enzyme-Inducing Drugs</h3></dt>
                    <dd>
                        (e.g., Carbamazepine, Phenytoin, Rifampicin, St John's Wort)<br>
                        Significantly reduce the effectiveness of <strong>CHC, POP, and the Implant</strong>.<br>
                        <strong>Recommended Methods:</strong> Cu-IUD, LNG-IUD, or the Progestogen-Only Injectable.
                    </dd>

                    <dt><h3>Teratogenic Drugs</h3></dt>
                    <dd>
                        (e.g., Sodium Valproate, Retinoids, Lithium)<br>
                        Pregnancy prevention is critical. Strongly advise a <strong>highly effective LARC method</strong> (Implant or IUC). The injectable is also suitable if compliance is documented. Avoid relying on user-dependent methods.
                    </dd>
                </dl>
            </section>
            
             <!-- Step 5 -->
            <section class="step-card">
                <h2><span class="step-number">5</span>Final Method-Specific Considerations</h2>
                <ul>
                    <li><strong>Intrauterine Contraception (IUC):</strong> Requires a bimanual pelvic exam prior to insertion. Assess for STI risk before fitting.</li>
                    <li><strong>Progestogen-Only Injectable (DMPA):</strong> Associated with a temporary reduction in bone mineral density. Use with caution in those with significant osteoporosis risk factors. Consider alternatives for adolescents unless other methods are unsuitable.</li>
                    <li><strong>Sterilization (Male or Female):</strong> Counsel thoroughly on permanence and the risk of regret, especially in those <30 years old or without children. Offer LARC methods as highly effective, reversible alternatives.</li>
                </ul>
            </section>
        </main>

        <footer>
            <p><strong>Disclaimer:</strong> This algorithm is a summary for quick reference. Always consult full, up-to-date NICE CKS and FSRH UKMEC guidelines for comprehensive information.</p>
        </footer>
    </div>

</body>
</html>